Viewing Study NCT06480019



Ignite Creation Date: 2024-07-17 @ 10:40 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06480019
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2024-06-24

Brief Title: IPT-based Group Intervention by Non-specialist for Improvement of Depressive Symptoms in Community Young Adults in Brazil
Sponsor: Hospital de Clinicas de Porto Alegre
Organization: Hospital de Clinicas de Porto Alegre

Study Overview

Official Title: IPT-based Group Intervention by Non-specialist for Improvement of Depressive Symptoms in Community Young Adults in Brazil a Randomized Clinical Trial
Status: RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Major depressive disorder is a highly prevalent recurrent and debilitating disease the third cause of years of lost life in the world and it may be the most common disease in 2030 according to the World Health Organization WHO Furthermore its also related to decreased quality of life and high mortality Interpersonal psychotherapy IPT is a first-line treatment and can also be used for the prevention of depression

This randomized controlled clinical trial is planned to have 50 participants randomized between an interventional and a control group waiting list Our study covers young adults 18 to 24 years old with depression Participants will be invited by social media to undergo treatment in an IPT group The intervention group will be separated into groups with up to 10 participants with a weekly meeting for eight weeks The intervention will focus on interpersonal relationships within the model of IPT and will be held by a university student and a doctor trained in IPT
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None